INTRODUCTION
Hypertriglyceridemia and hypercholesterolemia are established causative factors for the development of atherosclerosis and cardiovascular diseases. [1] A decrement of 20% in plasma TC can reduce not only 31% risk of coronary artery disease, but also the mortality rate by approximately 33%. [2] Several synthetic hypocholesteromic agents such as statins, Þ brates, resins and nicotinic acid are capable of efÞ ciently reducing plasma TC levels, [3, 4] but lowdensity lipoprotein (LDL) does not undergo any signiÞ cant of the aerial parts have shown presence of n-alkanes, longchain alcohols, sterols, ephedrine, sterculic acid, linoleic acid, phenyl ethylamine, cellulose and lignin. [11, 12] It has been shown to have antiinß ammatory, hepatoprotective, antibacterial effects and antinociceptive properties. [13] [14] [15] [16] It is also considered beneficial in controlling fever, cardiovascular disease and urinary disorders. [17] Previous studies from our laboratory have documented that aqueous leaf extract of SR has lipid lowering [18] and anti hypertriglyceridemic properties [19] , whereas methanolic extract of SR has shown to have antioxidant and free radical scavenging properties (Unpublished observations). Hence, this inventory is an effort to assess the effect of SR on the lipid proÞ le of experimentally induced hyperlipidemia in male Charles foster rats.
MATERIALS AND METHODS

Plant collection and identiÞ cation
Sida rhombodiea.Roxb (SR) leaves were collected from Imphal district of India in the month of June. The plant was identiÞ ed at the Department of Botany, D. M. College of Science, Manipur, Imphal and a sample (voucher specimen No.216) was deposited at the herbarium of the Department of Botany.
Preparation of methanolic extract
The leaves of the plant were washed and rinsed with tap water and shade dried. The dried leaves were subjected to extraction using methanol in soxhlet apparatus and resultant Þ ltrate was concentrated under reduced pressure by rotary evaporator (Buchi, Germany). A semisolid paste obtained by this process was stored at 0°C. The extractive value of the SR was 21% w/w, which was further dissolved in 0.5% carboxy methyl cellulose (CMC).
Experimental animals
Male Charles foster albino rats (220-250 g) were housed and maintained in clean polypropylene cages under controlled room temperature (22 ± 2ºC) and were fed with commercially available rat chow (SLD (Normal diet); M/s Pranav Agro Ltd., Vadodara, India) or high fat diet (HFD) [20] and provided with water ad libitum. Experiments on animals were performed in accordance with guidelines of the institutional animal ethical committee (Approval no. 827/ac/04/CPCSEA). At the end of the experimental period, overnight fasted animals (for 12 h) were given mild ether anesthesia and blood was collected by retro orbital sinus puncture in EDTA-coated vials. Plasma was obtained by cold centrifugation (4°C) of the vials for 10 min at 3000 rpm. Later animals were sacriÞ ced by decapitation and liver, pancreas, brain and epididymal fat pad were excised and stored at -80°C for further estimations.
Diet composition
Lipid proÞ le
Plasma TC, TG and HDL were analyzed using commercially available kits (Eve's diagnostic, Vadodara, India). VLDL and LDL were calculated by Friedewald's formula. [21] Hepatic and fecal lipids were extracted using chloroform: methanol (2:1) mixture and total lipids were estimated gravimetrically. Dried lipid extract was dissolved in 1% triton X 100 [22] and TC and TG were analyzed using the above mentioned kits.
Fecal cholic acid and deoxycholic acids (CA and DCA)
Fecal samples from each group were collected on every third day between days 31 and 42. Dried fecal samples were eluted with absolute alcohol, Þ ltered and CA and DCA were estimated by the method of Mosback et al. [23] Liver function assessment Activity levels of serum glutamate oxaloacetate transferase (SGOT, EC 2.6.1.1) and serum glutamate pyruvate transferase (SGPT, EC 2.6.1.2) were assayed in plasma of control and experimental rats using kits (Eve's diagnostic, Vadodara, India).
Statistical analysis
Statistical evaluation of the data was done by one way analysis of variance (ANOVA) followed by Bonferroni's multiple comparison test. The results are expressed as mean ± SEM using Graph Pad Prism version 3.0 for Windows, Graph Pad Software, San Diego, CA, U.S.A.
RESULTS
Body weight and food intake
HL group recorded higher body weight gain and feed efÞ ciency ratio compared to CN group (51% and 66.73%). However, there was no signiÞ cant change in food intake of HL vs CN group but was decreased in HL + SR400 (22.38%). HL + SR400 group recorded 36.71% decrement in body weight gain coupled with 46.38% decrement in feed efÞ ciency ratio. Although water intake was decreased by about 18.46% in HL + SR400 group, it was unchanged in other groups. HL + SS group recorded no signiÞ cant change in food and water intake, but recorded decrement in weight gain and feed efÞ ciency ratio (22.06% and 9.54%) as compared to HL group [ Table 1 ].
Liver and epididymal fat pad weight
The weight of epididymal fat pad recorded an increment of 37.65% in HL control group, while there was a decrement of 56.79% in HL+SR group compared to the HL group. The weight of liver increased by 26.54% in HL control group compared to the CN group, whereas it was decreased by 18.48% in HL + SR group compared to HL control group. HL+SS group was also found to exert favorable effect, but was not as effective as SR400. HL+SS group recorded 27.63% decrement in epididymal fat pad weight, but there was no signiÞ cant change in liver weight as compared to HL group [ 
Fecal lipids
The TL, TC, TG, CA, and DCA levels eliminated through 
Liver function assessment
Activity levels of plasma SGOT and SGPT were signiÞ cantly elevated (32.82 and 32.45%) in HL control group compared to the CN group and signiÞ cantly decreased (42.25 and 41.50%) in HL+SR400 group compared to the HL control group. HL+SS group recorded 16.7% decrement in SGOT levels whereas; there was no signiÞ cant change in SGPT levels as compared to HL group [ Table 4 ].
DISCUSSION
This study deals with the effect of SR (400 mg/kg BW) on plasma and hepatic lipid proÞ le and elimination of lipids through feaces in hyperlipidemic rats. There was a signiÞ cant reduction in plasma and hepatic lipid proÞ les along with elevation in plasma HDL in HL+SR400-treated rats as compared to HL rats, thus indicating the efÞ cacy of SR extract in preventing the elevation seen in various components of lipid proÞ le under experimentally induced hyperlipidemia. Epidemiological studies have shown that a higher level of HDL in plasma reduces the risk of coronary artery disease (CAD). [24] It is also reported that HDL is potentially capable of inhibiting LDL oxidation, protecting vascular endothelial cells from cytotoxic effects of Ox-LDL and preventing the advent of atherosclerosis. [25] Flavanoids are reported to increase HDL concentration and decrease LDL and VLDL levels in hypercholesteremic rats. [26] Flavanoids and polyphenols found in our SR extract could therefore be considered favorable in increasing HDL and decreasing LDL and VLDL in HL+SR400-treated rats.
HMG Co-A reductase is the key metabolic enzyme for the de novo synthesis of cholesterol in liver. [27] Hence, low levels of hepatic TC observed in SR-treated rats could be due to the inhibition of HMG Co-A reductase activity. [18] Further, low levels of cholesterol in liver are known to elevate LDL-R expression in hepatocytes and consequent withdrawal of LDL from circulation. [28] It can be assumed In this context that lowered LDL levels observed in HL+SR400 group could be attributed to an increased expression of LDL-R triggered by lowered hepatic TC levels. Hepatic cholesterol is catabolised into bile acids or converted to oxysterol that can stimulate cholesterol 7α hydroxylase to form bile acids. [29] Previous reports on antihyperlipidemic effect of some natural products suggested higher fecal bile excretion. [30] Hence, it can be speculated that HL+SR400 treatment may convert hepatic cholesterol into bile acids evidences by greater elimination of bile acids through feaces in the experimental group. Phytosterols are known to have cholesterol lowering property because of their greater afÞ nity for micelles than cholesterol. This results in reduced incorporation of cholesterol into micelles [31, 32] amounting to increased cholesterol elimination through feaces. Hence, high fecal cholesterol content recorded in HL+SR400 group in the present study could be attributed to a high content of phytosterol in the SR extract. Saponins have been correlated with inhibition of pancreatic lipase leading to reduced intestinal absorption and higher excretion of dietary fats. [33] Hence, high saponin content in our SR can be the possible reason for the higher elimination of TG through feaces of HL+SR400 treated rats. Previous studies have reported increased liver weight and signiÞ cantly elevated plasma levels of SGPT and SGOT under conditions of hyperlipidemia. [34] Results recorded in this study are in accordance with these reports as HL rats have recorded higher liver weight and impaired liver marked by elevated activity levels of plasma SGPT and SGOT. [35] SR treatment is able to reduce liver weight and plasma SGPT and SGOT levels thus indicating its hepatoprotective activity. A comparison of results obtained in this study with the lipid lowering potential of Simvastatin suggest that, SR is more effective in elevating circulating HDL levels and lowering TG and TC levels and in maintaining hepatic TG metabolism.
The results obtained with methanolic extract of SR are in accordance with our previous study, [18] wherein a crude extract of SR has been reported to have a dose-dependent lipid lowering property by a similar mechanisms as envisaged herein. This study is an addition to the existing information that the methanolic extract consisting of polar fraction of SR is equally potent as the crude extract. It was inferred from our previous study [19] that 400 mg/kg BW of crude extract was the most efÞ cient dose for lowering lipid and cholesterol levels in hyperlipidemic rats. Hence, this study further validates the efÞ cacy of methanolic extract of SR in the same dose. This report also provides an ideal platform for the isolation, puriÞ cation and characterization of known bioactive/novel compounds present in polar fraction of SR.
CONCLUSION
In continuation with the previous study from our lab, this report adds to the existing wealth of information on the possible therapeutic role of methanolic extract of SR in experimentally induced hyperlipidemia. A detailed investigation has been initiated in our laboratory to identify the active principles from methanolic extract. Hence, it can be concluded that Sida rhomboidea.Roxb methanolic extract has an excellent lipid lowering potential and also possess curative properties in conditions of hyperlipidemia and related disorders.
